Literature DB >> 9662196

Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London.

A Petruckevitch1, J Del Amo, A N Phillips, A M Johnson, J Stephenson, N Desmond, T Hanscheid, N Low, A Newell, A Obasi, K Paine, A Pym, C Theodore, K M De Cock.   

Abstract

OBJECTIVE: To assess the impact of specific AIDS-defining conditions on survival in HIV-infected persons, with emphasis on the effect of tuberculosis.
METHODS: A retrospective cohort analysis of HIV-infected Africans and non-Africans attending 11 specialist HIV/AIDS units in London enrolled for a comparison of the natural history of HIV/AIDS in different ethnic groups.
RESULTS: A total of 2048 patients were studied of whom 627 (31%) developed 1306 different AIDS indicator diseases. Pneumocystis carinii pneumonia accounted for 159 (25%) of initial AIDS episodes and tuberculosis for 103 (16%). In patients with HIV disease, tuberculosis had the lowest risk [relative risk (RR), 1.11; 95% confidence interval (CI), 0.75-1.63], and high-grade lymphoma had the highest risk (RR, 20.56; 95% CI, 2.70-156.54) for death. For patients with a prior AIDS-defining illness, the development of subsequent AIDS indicator diseases such as Pneumocystis carinii pneumonia (RR, 1.18; 95% CI, 0.77-1.83) and tuberculosis (RR, 1.36; 95% CI, 0.76-2.47) had the best survival, and non-Hodgkin's lymphoma had the worst survival (RR, 9.67; 95% CI, 1.26-74.33). Patients with tuberculosis had a lower incidence of subsequent AIDS-defining conditions than persons with other initial AIDS diagnoses (rate ratio, 0.47; 95% CI, 0.37-0.59).
CONCLUSIONS: Considerable variation exists in the relative risk of death following different AIDS-defining conditions. The development of any subsequent AIDS-defining condition is associated with an increased risk of death that differs between diseases, and this risk should be considered when evaluating the impact of specific conditions. Like other AIDS-defining conditions, incident tuberculosis was associated with adverse outcome compared with the absence of an AIDS-defining event, but we found no evidence of major acceleration of HIV disease attributable to tuberculosis.

Entities:  

Mesh:

Year:  1998        PMID: 9662196     DOI: 10.1097/00002030-199809000-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  AIDS related systemic non-Hodgkin's lymphoma.

Authors:  T Powles; G Matthews; M Bower
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

2.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

3.  Survival by AIDS defining condition in rural Uganda.

Authors:  D Morgan; S S Malamba; J Orem; B Mayanja; M Okongo; J A Whitworth
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

4.  Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study.

Authors:  Kanlaya Teerawattananon; Saniorn Iewsakul; Chawewan Yenjitr; Somsanguan Ausayakhun; Watanee Yenjitr; Miranda Mugford; Yot Teerawattananon
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.

Authors:  Alison J Rodger; Zoe Fox; Jens D Lundgren; Lewis H Kuller; Christoph Boesecke; Daniela Gey; Athanassios Skoutelis; Matthew Bidwell Goetz; Andrew N Phillips
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

6.  Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence.

Authors:  Hugo López-Gatell; Stephen R Cole; Joseph B Margolick; Mallory D Witt; Jeremy Martinson; John P Phair; Lisa P Jacobson
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

7.  Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.

Authors:  Michael G Milligan; Elizabeth Bigger; Jeremy S Abramson; Aliyah R Sohani; Musimar Zola; Mukendi K A Kayembe; Heluf Medhin; Gita Suneja; Shahin Lockman; Bruce A Chabner; Scott L Dryden-Peterson
Journal:  J Glob Oncol       Date:  2018-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.